![Alexandre Grassin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexandre Grassin
Corporate Officer/Principal chez
Calliditas Therapeutics Suisse SA
Profil
Alexandre Grassin is currently a Director at Calliditas Therapeutics Suisse SA. Previously, he worked as a Principal at Novartis AG from 2007 to 2010.
He also served as a Financial Auditor at KPMG SA. From 2010 to 2012, he was a Principal at Alexion Pharma GmbH.
Additionally, he held the position of Vice President-Finance & Administration at Calliditas Therapeutics France SAS. Mr. Grassin's most recent former position was as the Chief Financial Officer at enGene Holdings, Inc. in 2023.
Postes actifs de Alexandre Grassin
| Sociétés | Poste | Début |
|---|---|---|
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Corporate Officer/Principal | - |
Anciens postes connus de Alexandre Grassin
| Sociétés | Poste | Fin |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Directeur Financier/CFO | 29/11/2023 |
Alexion Pharma GmbH
 Alexion Pharma GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders | Corporate Officer/Principal | 01/01/2012 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2010 |
| GENKYOTEX SA. | Directeur Financier/CFO | - |
KPMG SA
 KPMG SA Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing and strategic advisory services | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
KPMG SA
KPMG SA Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing and strategic advisory services | Commercial Services |
Alexion Pharma GmbH
Alexion Pharma GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders | Health Technology |
Calliditas Therapeutics France SAS
 Calliditas Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Engages in biotechnology research and development | Commercial Services |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
